What Does Stochastic %K say about Celldex Therapeutics, Inc. (NASDAQ:CLDX)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Celldex Therapeutics, Inc. (NASDAQ:CLDX) for the period of 9-Day stands at 59.98% while the stochastic %D for the same period stands at 67.17%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Celldex Therapeutics, Inc. (NASDAQ:CLDX) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Celldex Therapeutics, Inc. (NASDAQ:CLDX) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex’s immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.

Previous Day Activity Analysis

On the last trading day, Celldex Therapeutics, Inc. (NASDAQ:CLDX) opened the session at $3.13 and after going down -0.97% closed at $3.07. The stock lost -0.06 points in the last trade.

Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s stock fluctuated in the range of $3.03 and $3.14 during the previous active session. Celldex Therapeutics, Inc. (NASDAQ:CLDX) traded with the volume of 1.16 Million with average volume of 1.43 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 2.67 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.14 and 63.36 respectively.

Currently the Insider Ownership of the shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) is at 0.4% and the shares outstanding are 129.61 Million.

Important Ratio Analysis

Some important ratios to consider here for Celldex Therapeutics, Inc. (NASDAQ:CLDX) are discussed below:

Dividend yield of Celldex Therapeutics, Inc. (NASDAQ:CLDX) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 41.88 and 1.66 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 2.58 and 0 correspondingly.

The Quick Ratio of Celldex Therapeutics, Inc. (NASDAQ:CLDX) stands at 5.6 while the Current Ratio depicts the value of 5.6.

Return on Assets ROA of Celldex Therapeutics, Inc. (NASDAQ:CLDX) is at -37.2% whereas, Return on Equity ROE and Return of Investment ROI of Celldex Therapeutics, Inc. (NASDAQ:CLDX) stand at -51.9% and -50.1% respectively.

Stock Performance Analysis

The stock performance of Celldex Therapeutics, Inc. (NASDAQ:CLDX) on the basis of 5 day trade show the dip of -2.85% whereas, the monthly performance of the stock shows increase of 19.92%.

The quarterly performance of the stock remained in green zone with the value of 27.92% while six month performance of the shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) remained bearish with the count of -5.25%.

The yearly and YTD performance of Celldex Therapeutics, Inc. (NASDAQ:CLDX) remained down at -14.96% and -13.28% respectively.